← Insider buys
AIMT

Aimmune Therapeutics, Inc.

Chief Medical Officer Daniel C Md Adelman sold $341K of Aimmune Therapeutics, Inc.

Sold$340,610
$34.06Price
10,000Shares
−100%Stake

What AIMT did after the filing

Prices for AIMT after this filing aren't in yet.

Traded Mon, Oct 23. Filed Wed, Oct 25, 12:05 PM ET, during the session. Not investment advice.